New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.96 2.22 +1.67%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

Merck & Co., Inc. (MRK) Net margin

Alert me on Net margin

Merck & Co., Inc.'s net margin over the twelve months to Sep 30, 2026 was 3.64%, down 24.4 percentage points from fiscal 2025 (28.1%). Over the past ten years it has ranged from 0.61% (fiscal 2023) to 28.1% (fiscal 2025) — the current reading is the highest in ten years. That is below the Drug Manufacturers General industry median of 7.31% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 28.1% 1.40
FY2024 26.7% 26.07
FY2023 0.61% (23.88)
FY2022 24.5% (2.30)
FY2021 26.8% 9.77
FY2020 17.0% (8.14)
FY2019 25.2% 10.45
FY2018 14.7% 8.74
FY2017 5.97% (3.88)
FY2016 9.85% (1.40)

Quarterly newest first

Period Net margin Change (points)
Sep 2026 28.0% 36.05
Jun 2026 −8.04% 17.99
Mar 2026 −26.0% (44.10)
Dec 2025 18.1% (15.42)
43 more quarters

Against its own ten years

Low 0.61% High 28.1%
Ten-year median 17.0%
Current reading's percentile 7

Net margin against peers

Company Net margin
NVO Novo Nordisk A/S compare 34.1%
AMGN Amgen Inc. compare 24.1%
AZN AstraZeneca PLC compare 17.7%
NVS Novartis AG compare 17.5%
JNJ Johnson & Johnson compare 16.2%
ABBV AbbVie Inc. compare 15.6%
PFE Pfizer Inc. compare 6.34%
MRK Merck & Co., Inc. 3.64%
GILD Gilead Sciences, Inc. compare −12.5%
Drug Manufacturers General industry median 7.31%
Healthcare sector median 0.00%
Market median 1.34%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on MRK